Stockscreener 앱 받기
92.03
1.08%
0.835
전일 마감가:
$91.19
열려 있는:
$91.34
하루 거래량:
67,105
Relative Volume:
0.78
시가총액:
$N/A
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+3.23%
1개월 성능:
+7.71%
6개월 성능:
+7.28%
1년 성능:
+43.20%
1일 변동 폭
$91.13
$92.48
1주일 범위
$88.74
$92.48
52주 변동 폭
$63.76
$92.48
Ishares U S Pharmaceuticals Etf Stock (IHE) Company Profile
Compare IHE vs VTI, SPY, IVV, VB, QQQ
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IHE
Ishares U S Pharmaceuticals Etf
|
92.11 | 0 | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
369.11 | 417.53B | 0 | 0 | 0 | 0.00 |
SPY
Spdr S P 500 Etf Trust
|
749.66 | 372.57B | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
753.19 | 253.41B | 0 | 0 | 0 | 0.00 |
VB
Vanguard Small Cap Etf
|
293.03 | 160.59B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
728.49 | 124.43B | 0 | 0 | 0 | 0.00 |
Ishares U S Pharmaceuticals Etf 주식(IHE)의 최신 뉴스
GLP-1 Drugs Powered IHE's Big Year. IXJ Is Playing a Longer Game. - The Motley Fool
GLP-1 Drugs Powered IHE's Big Year. IXJ Is Playing a Longer Game. - The Motley Fool
Precision Trading with Ishares U.s. Pharmaceuticals Etf (IHE) Risk Zones - Stock Traders Daily
Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now? - Yahoo Finance
iShares U.S. Pharmaceuticals ETF outperforms despite drug pricing policy risks, up 38% in 12 months. - Pluang
Ditch or Double Down on This Pharma ETF as Trump Adjusts Drug Prices? - Yahoo Finance
Should you invest in the iShares US Pharmaceuticals ETF (IHE)? - MSN
Healthcare sector undervalued, with iShares U.S. Pharmaceuticals ETF leading gains but risks from concentration exist. - Pluang
IHE: Healthcare Dashboard For May - Seeking Alpha
The Silver Tsunami: Healthcare ETFs to Buy Amid Aging US Demographics - The Globe and Mail
Pharma ETFs: Your Key to Diversification in the Pharmaceutical Sector - Investing News Network
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)? - Yahoo Finance
FDA commissioner raises concerns about US pharma lagging behind China in drug development - MSN
7 ETFs to Play a Healthcare Rebound - Barron's
7 ETFs to play a healthcare rebound - MSN
Healthcare Is Due for a Rebound. These ETFs Are a Good Way to Buy In. - Barron's
IHE: As AI Speeds Drug Research, this Pharmaceutical ETF Should Prosper - moneyshow.com
(05/04/26) IHE: As AI Speeds Drug Research, this Pharmaceutical ETF Should - moneyshow.com
IHE- As AI Speeds Drug Research, this Pharmaceutical ETF Should Prosper - Yahoo Finance
The pharmaceutical sector is surging. Here's 1 stock every investor should have on their radar. - MSN
Should You Invest in the Invesco Pharmaceuticals ETF (PJP)? - Yahoo Finance
Should You Invest in the iShares U.S. Healthcare Providers ETF (IHF)? - Yahoo Finance
Should You Invest in the iShares U.S. Medical Devices ETF (IHI)? - Yahoo Finance
Healthcare ETFs in Spotlight Amid Eli Lily's $2.8B AI Drug Move - MSN
iShares US Pharmaceuticals ETF declares quarterly distribution of $0.2845 - MSN
Should You Invest in the iShares U.S. Healthcare ETF (IYH)? - Yahoo Finance
What Johnson & Johnson Earnings Signal for Healthcare ETFs - ETF Trends
iShares U.S. Pharmaceuticals ETF (IHE) - Minichart
Anfield US Equity Sector Rotation ETF's iShares U.S. Pharmaceuticals ETF(IHE) Holding History - GuruFocus
Is State Street SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now? - sharewise.com
USA Stocks: Research Stocks from USA Stock Market - GuruFocus
Trump Administration Prepares Up To 100% Pharma Tariffs On Drugs From Companies That Have Not Struck A Deal Yet: Report - Stocktwits
Stock List: Research Stocks from Around the World - GuruFocus
Should You Invest in the VanEck Pharmaceutical ETF (PPH)? - Yahoo Finance
Should You Invest in the State Street SPDR S&P Pharmaceuticals ETF (XPH)? - sharewise.com
PPH ETF: Drug Pricing Policy and Eli Lilly Concentration Are the Two Risks to Watch in 2026 - 24/7 Wall St.
With Two Companies Dictating Everything, IHE Is Riskier Than Most Investors Realize - AOL.com
Is the Invesco Pharmaceuticals ETF (PJP) Currently a Top ETF Choice? - Bitget
Should you consider putting your money into the iShares U.S. Pharmaceuticals ETF (IHE)? - Bitget
Ishares U S Pharmaceuticals Etf (IHE) 재무 분석
Ishares U S Pharmaceuticals Etf (IHE)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.73%
0.09%
자본화:
|
볼륨(24시간):